Review: taking Allegra and Intuniv together


Summary

Drug interactions are reported among people who take Allegra and Intuniv together. This review analyzes the effectiveness and drug interactions between Allegra and Intuniv. It is created by eHealthMe based on reports of 34 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Allegra and Intuniv >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Allegra

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Allegra 26,285 users)

Intuniv

Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Intuniv 1,007 users)

On Aug, 24, 2016

34 people who take Allegra, Intuniv are studied.


Number of reports submitted per year:

Allegra and Intuniv drug interactions.

Drug effectiveness over time:

Allegra:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Intuniv:
  • < 1 month: 100.0% - (1 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Allegra:
  • female: 50.0% - (1 of 2 people)
  • male: 0.0% - (0 of 1 people)
Intuniv:
  • female: 0.0% - (0 of 1 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Allegra:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)
Intuniv:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 100.0% - (1 of 1 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • eye pain
  • muscle spasms
  • muscle twitching
  • insomnia
  • convulsion
  • excessive eye blinking
1 - 6 months:
  • convulsion
  • excessive eye blinking
  • eye pain
  • muscle spasms
  • muscle twitching
  • compulsive hoarding
2 - 5 years:
  • hypertension aggravated
5 - 10 years:
  • hypertension aggravated
not specified:
  • dizziness
  • fatigue
  • sinusitis
  • asthenia
  • dyspnoea
  • muscle spasms
  • respiratory failure
  • sepsis
  • anxiety
  • pain

Most common drug interactions by gender *:

female:
  • sinusitis
  • dyspnoea
  • respiratory failure
  • sepsis
  • anxiety
  • pain
  • asthma
  • bronchitis
  • dizziness
  • wheezing
male:
  • convulsion
  • excessive eye blinking
  • eye pain
  • muscle spasms
  • muscle twitching
  • fatigue
  • asthenia
  • chills
  • dizziness
  • hyperhidrosis

Most common drug interactions by age *:

2-9:
  • convulsion
  • excessive eye blinking
  • eye pain
  • muscle spasms
  • muscle twitching
  • diarrhoea
  • drug administration error
  • insomnia
  • vomiting
10-19:
  • abnormal behaviour
  • alanine aminotransferase increased
  • aspartate aminotransferase increased
  • compulsive hoarding
  • congenital pancreatic anomaly
  • depression
  • disturbance in attention
  • dysgeusia
  • multiple injuries
  • pancreatic pseudocyst
30-39:
  • anxiety
  • cholecystitis chronic
  • emotional distress
  • gallbladder injury
  • general physical health deterioration
  • injury
  • pain
40-49:
  • chills
  • dizziness
  • fatigue
  • hyperhidrosis
  • hypersomnia
  • lacrimation increased
  • lethargy
  • pain in extremity
  • pharyngolaryngeal pain
  • arthralgia
50-59:
  • antinuclear antibody increased
  • anxiety
  • aortic valve sclerosis
  • arthralgia
  • arthritis
  • asthenia
  • asthma
  • blister
  • brain natriuretic peptide decreased
  • breath sounds abnormal
60+:
  • respiratory failure
  • sepsis
  • sinusitis
  • abdominal discomfort
  • asthenia
  • bronchitis
  • confusional state
  • dizziness
  • dyspnoea
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Allegra and Intuniv?

Can you answer these questions?

More questions for: Allegra, Intuniv

You may be interested in these reviews

More reviews for: Allegra, Intuniv

On eHealthMe, Allegra (fexofenadine hydrochloride) is often used to treat hypersensitivity. Intuniv (guanfacine hydrochloride) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.